High-Dose, Short Cycle Radiation Treatments Ideal For Low To Moderate Risk Prostate Cancers
A pioneering type of high-dose, short cycle radiation treatments, one that provides only a small number of those doses to its patients, has shown to be…
A pioneering type of high-dose, short cycle radiation treatments, one that provides only a small number of those doses to its patients, has shown to be…
More evidence has emerged that hormone therapy treatment for those diagnosed with prostate cancer increases cardiovascular risks for patients.
At least one new study has revealed the relationship between aggressive chemotherapy prostate cancer treatments and the likelihood that the patient will…
A recent research study has shown that a new immunotherapy drug has proven effective in reducing prostate-specific antigen levels in a specific subset…
A team of scientists from Purdue University has banded together to put the brakes on aggressive prostate cancer by reducing its lethality through new…
Recent research into how prostate cancer reacts to hormone therapy has revealed a startling and paradoxical trend: in some cases, these cancers have…
Patients suffering from prostate cancer that undergo radical prostatectomy, followed up with adjuvant radiotherapy, fare better overall than those who…
A new clinical trial of two immunotherapy drugs to discover how effective this combination may be in treating aggressive prostate cancers has already…
After reviewing the results of a new clinical study, researchers have found that cryoablation — a minimally-invasive procedure using intense cold to…
Low Dose Rate (LDR) Brachytherapy has been found to be an effective adjuvant treatment method for high-risk prostate cancers when combined with other…